TreeWAS – Variant ID: rs78432537

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)

Hierarchical visualisation How to interpret this figure?

Click here to show this figure without filtering.

Click on a node to zoom (except terminal nodes).

Download this figure in format

Results table

Term	Risk posterior probability	No effect posterior probability	Protective posterior probability
I25 Chronic ischaemic heart disease	0.000	0.000	1.000
I25.1 Atherosclerotic heart disease	0.000	0.000	1.000
I20-I25 Ischaemic heart diseases	0.000	0.000	1.000
I21 Acute myocardial infarction	0.000	0.000	1.000
I25.8 Other forms of chronic ischaemic heart disease	0.000	0.003	0.997
I25.2 Old myocardial infarction	0.000	0.004	0.996
I21.9 Acute myocardial infarction, unspecified	0.000	0.005	0.995
I21.0 Acute transmural myocardial infarction of anterior wall	0.000	0.063	0.937
I21.1 Acute transmural myocardial infarction of inferior wall	0.000	0.093	0.907
I22 Subsequent myocardial infarction	0.000	0.099	0.901
I25.5 Ischaemic cardiomyopathy	0.000	0.101	0.899
I21.4 Acute subendocardial myocardial infarction	0.000	0.103	0.897
I24 Other acute ischaemic heart diseases	0.000	0.115	0.885
I20 Angina pectoris	0.000	0.132	0.868
I20.0 Unstable angina	0.000	0.170	0.830
I24.9 Acute ischaemic heart disease, unspecified	0.000	0.198	0.802
I22.1 Subsequent myocardial infarction of inferior wall	0.000	0.236	0.764
I21.2 Acute transmural myocardial infarction of other sites	0.000	0.239	0.761
I25.0 Atherosclerotic cardiovascular disease, so described	0.000	0.245	0.755
I22.0 Subsequent myocardial infarction of anterior wall	0.000	0.247	0.753
I21.3 Acute transmural myocardial infarction of unspecified site	0.000	0.249	0.751
I22.8 Subsequent myocardial infarction of other sites	0.000	0.261	0.739
I24.8 Other forms of acute ischaemic heart disease	0.000	0.271	0.729
I25.6 Silent myocardial ischaemia	0.000	0.283	0.717
I25.4 Coronary artery aneurysm	0.000	0.283	0.717
I23 Certain current complications following acute myocardial infarction	0.000	0.283	0.717
I21.X Presumed acute myicardial infaction (unconfirmed)	0.000	0.283	0.717
I20.9 Angina pectoris, unspecified	0.000	0.314	0.686
I25.3 Aneurysm of heart	0.000	0.341	0.658
I24.1 Dressler's syndrome	0.000	0.365	0.635
I22.9 Subsequent myocardial infarction of unspecified site	0.000	0.461	0.539
I23.8 Other current complications following acute myocardial infarction	0.000	0.486	0.514
I23.6 Thrombosis of atrium, auricular appendage and ventricle as current complications following acute myocardial infarction	0.000	0.486	0.514
I23.5 Rupture of papillary muscle as current complication following acute myocardial infarction	0.000	0.486	0.514
I23.4 Rupture of chordae tendineae as current complication following acute myocardial infarction	0.000	0.486	0.514
I23.3 Rupture of cardiac wall without haemopericardium as current complication following acute myocardial infarction	0.000	0.486	0.514
I23.2 Ventricular septal defect as current complication following acute myocardial infarction	0.000	0.486	0.514
I23.1 Atrial septal defect as current complication following acute myocardial infarction	0.000	0.486	0.514
I23.0 Haemopericardium as current complication following acute myocardial infarction	0.000	0.486	0.514
I24.0 Coronary thrombosis not resulting in myocardial infarction	0.000	0.508	0.492
I20.1 Angina pectoris with documented spasm	0.000	0.534	0.466
I20.8 Other forms of angina pectoris	0.000	0.633	0.367
Z95.1 Presence of aortocoronary bypass graft	0.000	0.836	0.164
Z95.5 Presence of coronary angioplasty implant and graft	0.000	0.841	0.159
Z95 Presence of cardiac and vascular implants and grafts	0.000	0.847	0.153
I25.9 Chronic ischaemic heart disease, unspecified	0.000	0.869	0.131
Z95.4 Presence of other heart-valve replacement	0.000	0.871	0.129
Z95.2 Presence of prosthetic heart valve	0.000	0.873	0.127
Z95.9 Presence of cardiac and vascular implant and graft, unspecified	0.000	0.903	0.097
Z95.3 Presence of xenogenic heart valve	0.000	0.910	0.090
Z95.0 Presence of cardiac pacemaker	0.000	0.927	0.073
Z95.8 Presence of other cardiac and vascular implants and grafts	0.000	0.936	0.064
N72 Inflammatory disease of cervix uteri	0.045	0.955	0.000
N70-N77 Inflammatory diseases of female pelvic organs	0.044	0.956	0.000
N77 Vulvovaginal ulceration and inflammation in diseases classified elsewhere	0.042	0.958	0.000
N77.1 Vaginitis, vulvitis and vulvovaginitis in infectious and parasitic diseases classified elsewhere	0.041	0.959	0.000
N73 Other female pelvic inflammatory diseases	0.040	0.960	0.000
N70 Salpingitis and oophoritis	0.039	0.961	0.000
N71 Inflammatory disease of uterus, except cervix	0.037	0.963	0.000
N73.6 Female pelvic peritoneal adhesions	0.037	0.963	0.000
N70.1 Chronic salpingitis and oophoritis	0.035	0.965	0.000
N71.1 Chronic inflammatory disease of uterus	0.033	0.967	0.000
N76 Other inflammation of vagina and vulva	0.033	0.967	0.000
N73.9 Female pelvic inflammatory disease, unspecified	0.032	0.968	0.000
N74 Female pelvic inflammatory disorders in diseases classified elsewhere	0.032	0.968	0.000
N77.8 Vulvovaginal ulceration and inflammation in other diseases classified elsewhere	0.030	0.970	0.000
N77.0 Ulceration of vulva in infectious and parasitic diseases classified elsewhere	0.030	0.970	0.000
T36-T50 Poisoning by drugs, medicaments and biological substances	0.030	0.970	0.000
N76.4 Abscess of vulva	0.029	0.971	0.000
N73.8 Other specified female pelvic inflammatory diseases	0.029	0.971	0.000
N73.5 Female pelvic peritonitis, unspecified	0.029	0.971	0.000
N73.4 Female chronic pelvic peritonitis	0.029	0.971	0.000
N73.3 Female acute pelvic peritonitis	0.029	0.971	0.000
N73.2 Unspecified parametritis and pelvic cellulitis	0.029	0.971	0.000
N73.1 Chronic parametritis and pelvic cellulitis	0.029	0.971	0.000
N73.0 Acute parametritis and pelvic cellulitis	0.029	0.971	0.000
T40 Poisoning by narcotics and psychodysleptics [hallucinogens]	0.029	0.971	0.000
T43 Poisoning by psychotropic drugs, not elsewhere classified	0.028	0.972	0.000
T40.2 Other opioids	0.028	0.972	0.000
N70.0 Acute salpingitis and oophoritis	0.028	0.972	0.000
T46 Poisoning by agents primarily affecting the cardiovascular system	0.028	0.972	0.000
T45 Poisoning by primarily systemic and haematological agents, not elsewhere classified	0.028	0.972	0.000
N71.0 Acute inflammatory disease of uterus	0.027	0.973	0.000
N70.9 Salpingitis and oophoritis, unspecified	0.026	0.974	0.000
N71.9 Inflammatory disease of uterus, unspecified	0.026	0.974	0.000
N76.8 Other specified inflammation of vagina and vulva	0.025	0.974	0.000
T46.6 Antihyperlipidaemic and antiarteriosclerotic drugs	0.025	0.975	0.000
T43.5 Other and unspecified antipsychotics and neuroleptics	0.025	0.975	0.000
T39 Poisoning by nonopioid analgesics, antipyretics and antirheumatics	0.024	0.976	0.000
T43.2 Other and unspecified antidepressants	0.024	0.976	0.000
N76.3 Subacute and chronic vulvitis	0.024	0.976	0.000
T45.2 Vitamins, not elsewhere classified	0.024	0.976	0.000
N76.5 Ulceration of vagina	0.024	0.976	0.000
N76.1 Subacute and chronic vaginitis	0.024	0.976	0.000
N76.6 Ulceration of vulva	0.024	0.976	0.000
T45.0 Antiallergic and antiemetic drugs	0.023	0.977	0.000
N74.8 Female pelvic inflammatory disorders in other diseases classified elsewhere	0.023	0.977	0.000
N74.4 Female chlamydial pelvic inflammatory disease	0.023	0.977	0.000
N74.3 Female gonococcal pelvic inflammatory disease	0.023	0.977	0.000
N74.2 Female syphilitic pelvic inflammatory disease	0.023	0.977	0.000
N74.1 Female tuberculous pelvic inflammatory disease	0.023	0.977	0.000
N74.0 Tuberculous infection of cervix uteri	0.023	0.977	0.000
T43.4 Butyrophenone and thioxanthene neuroleptics	0.023	0.977	0.000
T40.4 Other synthetic narcotics	0.023	0.977	0.000
T50 Poisoning by diuretics and other and unspecified drugs, medicaments and biological substances	0.023	0.977	0.000
T38 Poisoning by hormones and their synthetic substitutes and antagonists, not elsewhere classified	0.023	0.977	0.000
T43.3 Phenothiazine antipsychotics and neuroleptics	0.022	0.978	0.000
T46.4 Angiotensin-converting-enzyme inhibitors	0.022	0.978	0.000
T36 Poisoning by systemic antibiotics	0.022	0.978	0.000
T46.1 Calcium-channel blockers	0.022	0.978	0.000
T49 Poisoning by topical agents primarily affecting skin and mucous membrane and by ophthalmological, otorhinolarygological and dental drugs	0.021	0.978	0.000
T48 Poisoning by agents primarily acting on smooth and skeletal muscles and the respiratory system	0.021	0.978	0.000
T47 Poisoning by agents primarily affecting gastro-intestinal system	0.021	0.978	0.000
T41 Poisoning by anaesthetics and therapeutic gases	0.021	0.978	0.000
T37 Poisoning by other systemic anti-infectives and antiparasitics	0.021	0.978	0.000
T40.9 Other and unspecified psychodysleptics [hallucinogens]	0.021	0.979	0.000
T40.8 Lysergide [LSD]	0.021	0.979	0.000
T40.7 Cannabis (derivatives)	0.021	0.979	0.000
T40.5 Cocaine	0.021	0.979	0.000
T40.3 Methadone	0.021	0.979	0.000
T40.1 Heroin	0.021	0.979	0.000
T40.0 Opium	0.021	0.979	0.000
T45.5 Anticoagulants	0.021	0.979	0.000
T40.6 Other and unspecified narcotics	0.021	0.979	0.000
N75 Diseases of Bartholin's gland	0.021	0.979	0.000
T43.9 Psychotropic drug, unspecified	0.020	0.979	0.000
T43.8 Other psychotropic drugs, not elsewhere classified	0.020	0.979	0.000
T43.6 Psychostimulants with abuse potential	0.020	0.979	0.000
T43.1 Monoamine-oxidase-inhibitor antidepressants	0.020	0.979	0.000
T39.1 4-Aminophenol derivatives	0.020	0.980	0.000
T46.9 Other and unspecified agents primarily affecting the cardiovascular system	0.020	0.980	0.000
T46.8 Antivaricose drugs, including sclerosing agents	0.020	0.980	0.000
T46.7 Peripheral vasodilators	0.020	0.980	0.000
T46.5 Other antihypertensive drugs, not elsewhere classified	0.020	0.980	0.000
T46.3 Coronary vasodilators, not elsewhere classified	0.020	0.980	0.000
T46.2 Other antidysrhythmic drugs, not elsewhere classified	0.020	0.980	0.000
T46.0 Cardiac-stimulant glycosides and drugs of similar action	0.020	0.980	0.000
T45.9 Primarily systemic and haematological agent, unspecified	0.020	0.980	0.000
T45.8 Other primarily systemic and haematological agents	0.020	0.980	0.000
T45.7 Anticoagulant antagonists, vitamin K and other coagulants	0.020	0.980	0.000
T45.6 Fibrinolysis-affecting drugs	0.020	0.980	0.000
T45.4 Iron and its compounds	0.020	0.980	0.000
T45.3 Enzymes, not elsewhere classified	0.020	0.980	0.000
T45.1 Antineoplastic and immunosuppressive drugs	0.020	0.980	0.000
N76.2 Acute vulvitis	0.020	0.980	0.000
T44 Poisoning by drugs primarily affecting the autonomic nervous system	0.020	0.980	0.000
T39.3 Other nonsteroidal anti-inflammatory drugs [NSAID]	0.019	0.981	0.000
T43.0 Tricyclic and tetracyclic antidepressants	0.018	0.982	0.000
T39.8 Other nonopioid analgesics and antipyretics, not elsewhere classified	0.017	0.982	0.000
T50.9 Other and unspecified drugs, medicaments and biological substances	0.017	0.982	0.000
T38.3 Insulin and oral hypoglycaemic [antidiabetic] drugs	0.017	0.982	0.000
T39.9 Nonopioid analgesic, antipyretic and antirheumatic, unspecified	0.017	0.982	0.000
T39.4 Antirheumatics, not elsewhere classified	0.017	0.982	0.000
T39.2 Pyrazolone derivatives	0.017	0.982	0.000
N76.0 Acute vaginitis	0.017	0.983	0.000
T36.0 Penicillins	0.016	0.983	0.000
T50.8 Diagnostic agents	0.016	0.983	0.000
T50.7 Analeptics and opioid receptor antagonists	0.016	0.983	0.000
T50.6 Antidotes and chelating agents, not elsewhere classified	0.016	0.983	0.000
T50.5 Appetite depressants	0.016	0.983	0.000
T50.4 Drugs affecting uric acid metabolism	0.016	0.983	0.000
T50.3 Electrolytic, caloric and water-balance agents	0.016	0.983	0.000
T50.2 Carbonic-anhydrase inhibitors, benzothiadiazides and other diuretics	0.016	0.983	0.000
T50.1 Loop [high-ceiling] diuretics	0.016	0.983	0.000
T50.0 Mineralocorticoids and their antagonists	0.016	0.983	0.000
T38.9 Other and unspecified hormone antagonists	0.016	0.983	0.000
T38.8 Other and unspecified hormones and their synthetic substitutes	0.016	0.983	0.000
T38.7 Androgens and anabolic congeners	0.016	0.983	0.000
T38.6 Antigonadotrophins. antioestrogens, antiandrogens, not elsewhere classified	0.016	0.983	0.000
T38.5 Other oestrogens and progestogens	0.016	0.983	0.000
T38.4 Oral contraceptives	0.016	0.983	0.000
T38.2 Antithyroid drugs	0.016	0.983	0.000
T38.1 Thyroid hormones and substitutes	0.016	0.983	0.000
T38.0 Glucocorticoids and synthetic analogues	0.016	0.983	0.000
T42 Poisoning by antiepileptic, sedative-hypnotic and anti-Parkinsonism drugs	0.016	0.984	0.000
T36.9 Systemic antibiotic, unspecified	0.016	0.984	0.000
T36.8 Other systemic antibiotics	0.016	0.984	0.000
T36.7 Antifungal antibiotics, systemically used	0.016	0.984	0.000
T36.6 Rifamycins	0.016	0.984	0.000
T36.5 Aminoglycosides	0.016	0.984	0.000
T36.4 Tetracyclines	0.016	0.984	0.000
T36.3 Macrolides	0.016	0.984	0.000
T36.2 Chloramphenicol group	0.016	0.984	0.000
T36.1 Cefalosporins and other Beta-lactam antibiotics	0.016	0.984	0.000
D12.0 Caecum	0.016	0.984	0.000
T37.9 Systemic anti-infective and antiparasitic, unspecified	0.016	0.984	0.000
T37.8 Other specified systemic anti-infectives and antiparasitics	0.016	0.984	0.000
T37.5 Antiviral drugs	0.016	0.984	0.000
T37.4 Anthelminthics	0.016	0.984	0.000
T37.3 Other antiprotozoal drugs	0.016	0.984	0.000
T37.2 Antimalarials and drugs acting on other blood protozoa	0.016	0.984	0.000
T37.1 Antimycobacterial drugs	0.016	0.984	0.000
T37.0 Sulphonamides	0.016	0.984	0.000
T41.5 Therapeutic gases	0.016	0.984	0.000
T41.4 Anaesthetic, unspecified	0.016	0.984	0.000
T41.3 Local anaesthetics	0.016	0.984	0.000
T41.2 Other and unspecified general anaesthetics	0.016	0.984	0.000
T41.1 Intravenous anaesthetics	0.016	0.984	0.000
T41.0 Inhaled anaesthetics	0.016	0.984	0.000
T47.9 Agent primarily affecting the gastro-intestinal system, unspecified	0.016	0.984	0.000
T47.8 Other agents primarily affecting the gastro-intestinal system	0.016	0.984	0.000
T47.7 Emetics	0.016	0.984	0.000
T47.6 Antidiarrhoeal drugs	0.016	0.984	0.000
T47.5 Digestants	0.016	0.984	0.000
T47.4 Other laxatives	0.016	0.984	0.000
T47.3 Saline and osmotic laxatives	0.016	0.984	0.000
T47.2 Stimulant laxatives	0.016	0.984	0.000
T47.1 Other antacids and anti-gastric-secretion drugs	0.016	0.984	0.000
T47.0 Histamine H(2)-receptor antagonists	0.016	0.984	0.000
T48.7 Other and unspecified agents primarily acting on the respiratory system	0.016	0.984	0.000
T48.6 Antiasthmatics, not elsewhere classified	0.016	0.984	0.000
T48.5 Anti-common-cold drugs	0.016	0.984	0.000
T48.4 Expectorants	0.016	0.984	0.000
T48.3 Antitussives	0.016	0.984	0.000
T48.2 Other and unspecified agents primarily acting on muscles	0.016	0.984	0.000
T48.1 Skeletal muscle relaxants [neuromuscular blocking agents]	0.016	0.984	0.000
T48.0 Oxytocic drugs	0.016	0.984	0.000
T49.9 Topical agent, unspecified	0.016	0.984	0.000
T49.8 Other topical agents	0.016	0.984	0.000
T49.7 Dental drugs, topically applied	0.016	0.984	0.000
T49.6 Otorhinolaryngological drugs and preparations	0.016	0.984	0.000
T49.5 Ophthalmological drugs and preparations	0.016	0.984	0.000
T49.4 Keratolytics, keratoplastics and other hair treatment drugs and preparations	0.016	0.984	0.000
T49.3 Emollients, demulcents and protectants	0.016	0.984	0.000
T49.2 Local astringents and local detergents	0.016	0.984	0.000
T49.1 Antipruritics	0.016	0.984	0.000
T49.0 Local antifungal, anti-infective and anti-inflammatory drugs, not elsewhere classified	0.016	0.984	0.000
T39.0 Salicylates	0.016	0.984	0.000
N75.9 Disease of Bartholin's gland, unspecified	0.015	0.985	0.000
N75.8 Other diseases of Bartholin's gland	0.015	0.985	0.000
T44.9 Other and unspecified drugs primarily affecting the nervous system	0.014	0.986	0.000
T44.8 Centrally acting and afrenergic-neuron-blocking agents, not elsewhere classified	0.014	0.986	0.000
T44.6 Alpha-Adrenoreceeptor antagonists, not elsewhere classified	0.014	0.986	0.000
T44.5 Predominantly Beta-adrenoreceptor agonists, not elsewhere classified	0.014	0.986	0.000
T44.4 Predominantly Alpha-adrenoreceptor agonists, not elsewhere classified	0.014	0.986	0.000
T44.3 Other parasympatholytics [anticholinergics and antimuscarines] and spasmolytics, not elsewhere classified	0.014	0.986	0.000
T44.2 Ganglionic blocking drugs, not elsewhere classified	0.014	0.986	0.000
T44.1 Other parasympathomimetics [cholinergics]	0.014	0.986	0.000
T44.0 Anticholinesterase agents	0.014	0.986	0.000
T44.7 Beta-Adrenoreceeptor antagonists, not elsewhere classified	0.012	0.988	0.000
Z51.0 Radiotherapy session	0.012	0.988	0.000
T42.8 Anti-Parkinsonism drugs and other central muscle-tone depressants	0.012	0.988	0.000
T42.7 Antiepileptic and sedative-hypnotic drugs, unspecified	0.012	0.988	0.000
T42.5 Mixed antiepileptics, not elsewhere classified	0.012	0.988	0.000
T42.3 Barbiturates	0.012	0.988	0.000
T42.2 Succinimides and oxazolidinediones	0.012	0.988	0.000
T42.1 Iminostilbenes	0.012	0.988	0.000
T42.0 Hydantoin derivatives	0.012	0.988	0.000
N75.0 Cyst of Bartholin's gland	0.011	0.988	0.000
N75.1 Abscess of Bartholin's gland	0.010	0.989	0.000
T42.6 Other antiepileptic and sedative-hypnotic drugs	0.010	0.990	0.000
T42.4 Benzodiazepines	0.009	0.991	0.000
M75.1 Rotator cuff syndrome	0.000	0.994	0.006
H00.1 Chalazion	0.006	0.994	0.000
I84.6 Residual haemorrhoidal skin tags	0.000	0.994	0.006
J44.0 Chronic obstructive pulmonary disease with acute lower respiratory infection	0.000	0.994	0.006
C79.5 Secondary malignant neoplasm of bone and bone marrow	0.005	0.995	0.000
D12 Benign neoplasm of colon, rectum, anus and anal canal	0.005	0.995	0.000
D12.9 Anus and anal canal	0.005	0.995	0.000
D26.0 Cervix uteri	0.005	0.995	0.000
D26.1 Corpus uteri	0.005	0.995	0.000
D12.7 Rectosigmoid junction	0.005	0.995	0.000
D12.6 Colon, unspecified	0.005	0.995	0.000
D26 Other benign neoplasms of uterus	0.005	0.995	0.000
D12.1 Appendix	0.004	0.996	0.000
C79 Secondary malignant neoplasm of other sites	0.004	0.996	0.000
D35.0 Adrenal gland	0.004	0.996	0.000
C79.9 Secondary malignant neoplasm, unspecified site	0.004	0.996	0.000
C79.4 Secondary malignant neoplasm of other and unspecified parts of nervous system	0.004	0.996	0.000
D26.9 Uterus, unspecified	0.004	0.996	0.000
C79.7 Secondary malignant neoplasm of adrenal gland	0.004	0.996	0.000
C79.2 Secondary malignant neoplasm of skin	0.004	0.996	0.000
D26.7 Other parts of uterus	0.004	0.996	0.000
E89.0 Postprocedural hypothyroidism	0.000	0.996	0.004
G62.9 Polyneuropathy, unspecified	0.000	0.996	0.004
N41.0 Acute prostatitis	0.004	0.996	0.000
D35 Benign neoplasm of other and unspecified endocrine glands	0.003	0.996	0.000
H00 Hordeolum and chalazion	0.003	0.997	0.000
N41.1 Chronic prostatitis	0.003	0.997	0.000
O87.2 Haemorrhoids in the puerperium	0.003	0.997	0.000
R60.9 Oedema, unspecified	0.003	0.997	0.000
D10-D36 Benign neoplasms	0.003	0.997	0.000
C79.1 Secondary malignant neoplasm of bladder and other and unspecified urinary organs	0.003	0.997	0.000
D12.5 Sigmoid colon	0.003	0.997	0.000
D24 Benign neoplasm of breast	0.003	0.997	0.000
H00.0 Hordeolum and other deep inflammation of eyelid	0.003	0.997	0.000
D30 Benign neoplasm of urinary organs	0.003	0.997	0.000
D68.9 Coagulation defect, unspecified	0.000	0.997	0.003
D35.1 Parathyroid gland	0.003	0.997	0.000
C79.6 Secondary malignant neoplasm of ovary	0.003	0.997	0.000
D31 Benign neoplasm of eye and adnexa	0.003	0.997	0.000
D13.2 Duodenum	0.003	0.997	0.000
D10 Benign neoplasm of mouth and pharynx	0.003	0.997	0.000
N41 Inflammatory diseases of prostate	0.003	0.997	0.000
K80.4 Calculus of bile duct with cholecystitis	0.003	0.997	0.000
D68.2 Hereditary deficiency of other clotting factors	0.000	0.997	0.003
D15 Benign neoplasm of other and unspecified intrathoracic organs	0.003	0.997	0.000
R50.9 Fever, unspecified	0.003	0.997	0.000
D16 Benign neoplasm of bone and articular cartilage	0.003	0.997	0.000
D35.9 Endocrine gland, unspecified	0.003	0.997	0.000
D35.8 Pluriglandular involvement	0.003	0.997	0.000
D35.7 Other specified endocrine glands	0.003	0.997	0.000
D35.6 Aortic body and other paraganglia	0.003	0.997	0.000
D35.5 Carotid body	0.003	0.997	0.000
D35.4 Pineal gland	0.003	0.997	0.000
D35.3 Craniopharyngeal duct	0.003	0.997	0.000
D30.0 Kidney	0.003	0.997	0.000
D30.3 Bladder	0.003	0.997	0.000
D13 Benign neoplasm of other and ill-defined parts of digestive system	0.003	0.997	0.000
D32 Benign neoplasm of meninges	0.003	0.997	0.000
C79.0 Secondary malignant neoplasm of kidney and renal pelvis	0.003	0.997	0.000
D16.3 Short bones of lower limb	0.003	0.997	0.000
D20 Benign neoplasm of soft tissue of retroperitoneum and peritoneum	0.003	0.997	0.000
D19 Benign neoplasm of mesothelial tissue	0.003	0.997	0.000
D68 Other coagulation defects	0.000	0.997	0.003
D31.3 Choroid	0.002	0.997	0.000
D15.0 Thymus	0.002	0.997	0.000
D31.0 Conjunctiva	0.002	0.997	0.000
D33 Benign neoplasm of brain and other parts of central nervous system	0.002	0.997	0.000
D18 Haemangioma and lymphangioma, any site	0.003	0.997	0.000
M81.90 Osteoporosis, unspecified (Multiple sites)	0.000	0.997	0.002
D11 Benign neoplasm of major salivary glands	0.002	0.997	0.000
D10.0 Lip	0.002	0.997	0.000
D30.9 Urinary organ, unspecified	0.002	0.997	0.000
D30.7 Other urinary organs	0.002	0.997	0.000
D30.4 Urethra	0.002	0.997	0.000
D30.2 Ureter	0.002	0.997	0.000
D30.1 Renal pelvis	0.002	0.997	0.000
D28 Benign neoplasm of other and unspecified female genital organs	0.002	0.997	0.000
D68.8 Other specified coagulation defects	0.000	0.998	0.002
D21 Other benign neoplasms of connective and other soft tissue	0.002	0.998	0.000
D18.1 Lymphangioma, any site	0.002	0.998	0.000
N80.9 Endometriosis, unspecified	0.002	0.998	0.000
D10.1 Tongue	0.002	0.998	0.000
D10.3 Other and unspecified parts of mouth	0.002	0.998	0.000
D31.9 Eye, unspecified	0.002	0.998	0.000
D31.6 Orbit, unspecified	0.002	0.998	0.000
D31.5 Lachrymal gland and duct	0.002	0.998	0.000
D31.4 Ciliary body	0.002	0.998	0.000
D31.2 Retina	0.002	0.998	0.000
D31.1 Cornea	0.002	0.998	0.000
D33.4 Spinal cord	0.002	0.998	0.000
D37.4 Colon	0.002	0.998	0.000
C79.3 Secondary malignant neoplasm of brain and cerebral meninges	0.002	0.998	0.000
D29 Benign neoplasm of male genital organs	0.002	0.998	0.000
D34 Benign neoplasm of thyroid gland	0.002	0.998	0.000
D10.9 Pharynx, unspecified	0.002	0.998	0.000
D10.7 Hypopharynx	0.002	0.998	0.000
D10.6 Nasopharynx	0.002	0.998	0.000
D10.5 Other parts of oropharynx	0.002	0.998	0.000
D10.4 Tonsil	0.002	0.998	0.000
D10.2 Floor of mouth	0.002	0.998	0.000
N41.8 Other inflammatory diseases of prostate	0.002	0.998	0.000
N41.3 Prostatocystitis	0.002	0.998	0.000
N41.2 Abscess of prostate	0.002	0.998	0.000
D15.9 Intrathoracic organ, unspecified	0.002	0.998	0.000
D15.7 Other specified intrathoracic organs	0.002	0.998	0.000
D15.2 Mediastinum	0.002	0.998	0.000
D15.1 Heart	0.002	0.998	0.000
D12.4 Descending colon	0.002	0.998	0.000
D16.2 Long bones of lower limb	0.002	0.998	0.000
N41.9 Inflammatory disease of prostate, unspecified	0.002	0.998	0.000
D16.9 Bone and articular cartilage, unspecified	0.002	0.998	0.000
D16.8 Pelvic bones, sacrum and coccyx	0.002	0.998	0.000
D16.7 Ribs, sternum and clavicle	0.002	0.998	0.000
D16.6 Vertebral column	0.002	0.998	0.000
D16.5 Lower jaw bone	0.002	0.998	0.000
D16.0 Scapula and long bones of upper limb	0.002	0.998	0.000
D32.0 Cerebral meninges	0.002	0.998	0.000
G62 Other polyneuropathies	0.000	0.998	0.002
D13.9 Ill-defined sites within the digestive system	0.002	0.998	0.000
D13.7 Endocrine pancreas	0.002	0.998	0.000
D13.6 Pancreas	0.002	0.998	0.000
D13.4 Liver	0.002	0.998	0.000
D13.3 Other and unspecified parts of small intestine	0.002	0.998	0.000
D21.2 Connective and other soft tissue of lower limb, including hip	0.002	0.998	0.000
D32.1 Spinal meninges	0.002	0.998	0.000
D11.9 Major salivary gland, unspecified	0.002	0.998	0.000
D21.5 Connective and other soft tissue of pelvis	0.002	0.998	0.000
D35.2 Pituitary gland	0.002	0.998	0.000
D16.4 Bones of skull and face	0.002	0.998	0.000
D16.1 Short bones of upper limb	0.002	0.998	0.000
D32.9 Meninges, unspecified	0.002	0.998	0.000
D68.0 Von Willebrand's disease	0.000	0.998	0.002
D14 Benign neoplasm of middle ear and respiratory system	0.002	0.998	0.000
D19.9 Mesothelial tissue, unspecified	0.002	0.998	0.000
D19.7 Mesothelial tissue of other sites	0.002	0.998	0.000
D19.1 Mesothelial tissue of peritoneum	0.002	0.998	0.000
D19.0 Mesothelial tissue of pleura	0.002	0.998	0.000
D20.1 Peritoneum	0.002	0.998	0.000
D20.0 Retroperitoneum	0.002	0.998	0.000
D68.5 Primary Thrombophilia	0.000	0.998	0.002
D68.4 Acquired coagulation factor deficiency	0.000	0.998	0.002
D68.1 Hereditary factor XI deficiency	0.000	0.998	0.002
H83.0 Labyrinthitis	0.000	0.998	0.002
O87 Venous complications in the puerperium	0.002	0.998	0.000
D28.2 Uterine tubes and ligaments	0.002	0.998	0.000
K80.5 Calculus of bile duct without cholangitis or cholecystitis	0.002	0.998	0.000
C77.9 Lymph node, unspecified	0.002	0.998	0.000
K80 Cholelithiasis	0.002	0.998	0.000
C77.5 Intrapelvic lymph nodes	0.002	0.998	0.000
D33.9 Central nervous system, unspecified	0.002	0.998	0.000
D33.7 Other specified parts of central nervous system	0.002	0.998	0.000
D33.2 Brain, unspecified	0.002	0.998	0.000
D33.1 Brain, infratentorial	0.002	0.998	0.000
D33.0 Brain, supratentorial	0.002	0.998	0.000
D11.7 Other major salivary glands	0.002	0.998	0.000
D13.5 Extrahepatic bile ducts	0.002	0.998	0.000
K80.1 Calculus of gallbladder with other cholecystitis	0.002	0.998	0.000
D28.9 Female genital organ, unspecified	0.002	0.998	0.000
D28.7 Other specified female genital organs	0.002	0.998	0.000
D28.1 Vagina	0.002	0.998	0.000
C22.0 Liver cell carcinoma	0.002	0.998	0.000
C77.3 Axillary and upper limb lymph nodes	0.002	0.998	0.000
D21.9 Connective and other soft tissue, unspecified	0.002	0.998	0.000
D21.6 Connective and other soft tissue of trunk, unspecified	0.002	0.998	0.000
D21.4 Connective and other soft tissue of abdomen	0.002	0.998	0.000
D21.3 Connective and other soft tissue of thorax	0.002	0.998	0.000
D68.3 Haemorrhagic disorder due to circulating anticoagulants	0.000	0.998	0.002
I74.3 Embolism and thrombosis of arteries of the lower extremities	0.002	0.998	0.000
F05.9 Delirium, unspecified	0.000	0.998	0.002
C77 Secondary and unspecified malignant neoplasm of lymph nodes	0.002	0.998	0.000
C76-C80 Malignant neoplasms of ill-defined, secondary and unspecified sites	0.002	0.998	0.000
D13.0 Oesophagus	0.002	0.998	0.000
D29.9 Male genital organ, unspecified	0.002	0.998	0.000
D29.7 Other male genital organs	0.002	0.998	0.000
D29.4 Scrotum	0.002	0.998	0.000
D29.3 Epididymis	0.002	0.998	0.000
D29.2 Testis	0.002	0.998	0.000
D29.0 Penis	0.002	0.998	0.000
G62.8 Other specified polyneuropathies	0.000	0.998	0.002
D23.3 Skin of other and unspecified parts of face	0.002	0.998	0.000
S82.10 Fracture of upper end of tibia (closed)	0.002	0.998	0.000
D68.6 Other Thrombophilia	0.000	0.998	0.002
Z85.4 Personal history of malignant neoplasm of genital organs	0.002	0.998	0.000
D13.1 Stomach	0.002	0.998	0.000
G62.2 Polyneuropathy due to other toxic agents	0.000	0.998	0.002
G62.1 Alcoholic polyneuropathy	0.000	0.998	0.002
C22 Malignant neoplasm of liver and intrahepatic bile ducts	0.002	0.998	0.000
G56.0 Carpal tunnel syndrome	0.000	0.998	0.002
C01 Malignant neoplasm of base of tongue	0.002	0.998	0.000
C77.4 Inguinal and lower limb lymph nodes	0.002	0.998	0.000
D36 Benign neoplasm of other and unspecified sites	0.002	0.998	0.000
C22.9 Liver, unspecified	0.002	0.998	0.000
N21.0 Calculus in bladder	0.002	0.998	0.000
R79.8 Other specified abnormal findings of blood chemistry	0.000	0.998	0.002
C69.3 Choroid	0.002	0.998	0.000
D14.4 Respiratory system, unspecified	0.002	0.998	0.000
D14.3 Bronchus and lung	0.002	0.998	0.000
D14.2 Trachea	0.002	0.998	0.000
G62.0 Drug-induced polyneuropathy	0.000	0.998	0.002
N88.8 Other specified noninflammatory disorders of cervix uteri	0.002	0.998	0.000
D23.2 Skin of ear and external auricular canal	0.002	0.998	0.000
D23 Other benign neoplasms of skin	0.002	0.998	0.000
D28.0 Vulva	0.002	0.998	0.000
D23.6 Skin of upper limb, including shoulder	0.002	0.998	0.000
O87.9 Venous complication in the puerperium, unspecified	0.002	0.998	0.000
O87.8 Other venous complications in the puerperium	0.002	0.998	0.000
O87.3 Cerebral venous thrombosis in the puerperium	0.002	0.998	0.000
O87.1 Deep phlebothrombosis in the puerperium	0.002	0.998	0.000
O87.0 Superficial thrombophlebitis in the puerperium	0.002	0.998	0.000
K80.3 Calculus of bile duct with cholangitis	0.002	0.998	0.000
D21.0 Connective and other soft tissue of head, face and neck	0.002	0.998	0.000
H73.8 Other specified disorders of tympanic membrane	0.002	0.998	0.000
M75.2 Bicipital tendinitis	0.000	0.998	0.002
D45 Polycythaemia vera	0.002	0.998	0.000
C22.1 Intrahepatic bile duct carcinoma	0.002	0.998	0.000
M25.77 Osteophyte (Ankle and foot)	0.002	0.998	0.000
K80.8 Other cholelithiasis	0.002	0.998	0.000
D29.1 Prostate	0.001	0.998	0.000
C76 Malignant neoplasm of other and ill-defined sites	0.002	0.998	0.000
E89 Postprocedural endocrine and metabolic disorders, not elsewhere classified	0.000	0.998	0.002
C77.8 Lymph nodes of multiple regions	0.002	0.998	0.000
C69 Malignant neoplasm of eye and adnexa	0.002	0.998	0.000
C21.0 Anus, unspecified	0.002	0.998	0.000
D11.0 Parotid gland	0.002	0.998	0.000
C22.7 Other specified carcinomas of liver	0.001	0.998	0.000
C22.4 Other sarcomas of liver	0.001	0.998	0.000
C22.3 Angiosarcoma of liver	0.001	0.998	0.000
C22.2 Hepatoblastoma	0.001	0.998	0.000
D14.0 Middle ear, nasal cavity and accessory sinuses	0.001	0.998	0.000
K80.2 Calculus of gallbladder without cholecystitis	0.002	0.998	0.000
M81.9 Osteoporosis, unspecified	0.000	0.998	0.002
N99.0 Postprocedural renal failure	0.002	0.998	0.000
C16.3 Pyloric antrum	0.002	0.998	0.000
D14.1 Larynx	0.001	0.998	0.000
D36.9 Benign neoplasm of unspecified site	0.001	0.998	0.000
D36.0 Lymph nodes	0.001	0.998	0.000
K74.6 Other and unspecified cirrhosis of liver	0.000	0.998	0.002
D25 Leiomyoma of uterus	0.002	0.998	0.000
M24.02 Loose body in joint (Upper arm)	0.002	0.998	0.000
N80.1 Endometriosis of ovary	0.002	0.998	0.000
D12.2 Ascending colon	0.002	0.998	0.000
D23.4 Skin of scalp and neck	0.002	0.998	0.000
M75 Shoulder lesions	0.000	0.998	0.002
C79.8 Secondary malignant neoplasm of other specified sites	0.001	0.998	0.000
M24.07 Loose body in joint (Ankle and foot)	0.001	0.998	0.000
M81.98 Osteoporosis, unspecified (Other)	0.000	0.998	0.002
C16.9 Stomach, unspecified	0.002	0.998	0.000
K80.36 Calculus of bile duct with acute and chronic cholangitis without obstruction	0.001	0.998	0.000

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.

The TreeWAS Database is the result of research conducted at the Oxford Big Data Institute at the University of Oxford.

This research has been conducted using the UK Biobank Resource (application number 10625). This work uses data provided by patients and collected by the NHS as part of their care and support.

This research has been conducted with the support of the Wellcome Trust (100956/Z/13/Z and 090532/Z/09/Z and 100308/Z/12/Z), the Danish National Research Foundation, Takeda, the Medical Research Council (MC_UU_12010/3), the Oak Foundation (OCAY-15-520), the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), the Wellcome Trust/Royal Society (204290/Z/16/Z) and the Li Ka Shing Foundation.

Variant-specific associations